Thursday, October 13, 2011

Blue Shield will return $295 million by the end of 2011

Here's why I only sell Blue Shield CA:

We are pleased to announce a second give-back as part our 2 Percent Pledge commitment to customers and the community. This time we will return an estimated $295 million based on our 2011 net earnings by the end of the year.

We announced the 2 Percent Pledge in June, as part of our commitment to affordability. We pledged to limit our annual net income to 2 percent of revenue, and any year that we earn more than 2 percent net income, to return the difference to our customers and the community. We started this commitment with our net income earned in 2010, and this month we returned $180 million based on 2010 net earnings to your clients and our local communities.

For fiscal year 2011, the estimated $295 million will be given back in the following ways:
  • Approximately $283 million will be credited back to customers on their December bills. The credit amounts will be determined based on a percentage of their August 2011 dues and/or premiums.

    • Individual (including Medicare Supplement) and fully-insured group customers will each get a 54 percent credit against one month of dues/premiums.

    • Customers with whom we share risk, such as CalPERS, will each get an 18 percent credit against one month of dues/premiums.
Customers with continuous fully-insured coverage in the same eligible product from August 1 through December 1, 2011 (other than certain government programs, like Medicare Advantage and Medicare Prescription Drug Plans, whose contracts do not provide a way to give such credits) are eligible for the credit. The average credit will vary depending on the monthly premiums.

  • $10 million in additional funds will be awarded to provider groups that applied for grants to help them participate in Accountable Care Organizations (ACOs) after our last pledge announcement.

  • $2 million will support a future community investment with more details to come.

No comments:

Post a Comment